We are monitoring the impact of COVID-19 & Recession alarm on MEA Nucleic Acid Labelling Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Nucleic Acid Labelling Market Research Report – Segmented By Product, Labelling Technique, Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2818
Pages: 145

MEA Nucleic Acid Labelling Market Size (2022 to 2027)

The Nucleic Acid Labelling Market size in the Middle East & Africa was valued at USD 120.46 Million in 2022 and estimated to grow at a CAGR of 8.97% to reach USD 185.08 million by USD 2027.

Factors such as rising healthcare expenditure, increased funding for genomics and disease diagnosis research, and increasing demand for personalized healthcare are driving the Middle East and Africa nucleic acid labeling market. For example, scientists can modify drugs to be more effective, improving treatment outcomes using genomic information. Furthermore, by categorizing diseases based on genetic variation rather than symptoms, this technique might be used to discover and diagnose diseases in a targeted manner, attracting many patients and promoting the nucleic acid labelling sector.

One of the other key drivers of the nucleic acid labelling market in the Middle East and Africa during the projected period is the rising incidence of chronic diseases leading to diabetes and other cardiovascular diseases and patient demand for tailored medications.

The genomes of numerous species, from bacteria to humans, have been entirely sequenced thanks to the astonishing advancement of sequencing technology. Furthermore, the recent introduction of Next Generation Sequencing (NGS) methods, which previously followed standard capillary sequencing methods, has substantially improved the sequencing pace. NGS technologies analyze various quantities and types of DNA libraries in a more precise, quick, and economical manner and in a more generalized manner, which is propelling the industry. In addition, NGS offers powerful tools for uncovering vital biological information such as whole genome sequences, DNA protein variants, and interactions and for diagnostic and therapeutic applications, assisting the Middle East and Africa market's growth.

However, the government's strict rules and regulations governing the approval of newly manufactured reference products are currently inhibiting market expansion in this region. A scarcity of competent personnel further hampers the market's demand to supervise procedures. The cost of installing and maintaining total equipment is quite high, and market developers have found this to be a difficult task. During the projection period, the nucleic acid labelling industry would face considerable headwinds due to a scarcity of competent professionals. Furthermore, due to a shortage of skilled professionals familiar with the interpretation of HCV test findings, it isn't easy to know when further specialized testing should be performed and which tests should be considered.

This research report on the MEA Nucleic Acid Labelling Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Reagents and Kits
  • Services

By Labelling Technique: 

  • PCR
  • Nick Translation
  • Random Primer
  • In-Vitro Transcription
  • Reverse Transcription

By Application: 

  • DNA Sequencing
  • PCR
  • Fluorescence in Situ Hybridization (FISH)
  • Microarrays
  • Blotting
  • In-Situ Hybridization

By End Users: 

  • Diagnostic Centres
  • Research Centres
  • Hospitals

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Initiatives by the governmental and private groups are propelling the expansion of the nucleic acid labelling sector in the Middle East and Africa. The growing popularity of designing synthetic genomes using various technologies accessible in the biotechnology area primarily meets the market demand. In addition, increasing government assistance by modifying schemes in favor of regular people provides market actors with growth chances. An increase in disposable income is another aspect influencing market demand. Furthermore, the business is being driven by a shift in public perception of personalized medicine.

Saudi Arabia is expected to dominate the Middle East and Africa Nucleic Acid Labelling market during the projected period. Public and private sector initiatives are accelerating the expansion of the nucleic acid labelling industry. In addition, the growing popularity of designing synthetic genomes using various technologies accessible in the biotechnology area is primarily to meet market demand.

Israel is predicted to hold the most significant share of the Middle East and Africa nucleic acid labeling market after Saudi Arabia during the forecast period. The primary growth driver has increased investments in research and development centers to introduce new products. In addition, the market's demand is being fueled by a growing focus on genomics.

KEY MARKET PLAYERS:

Companies playing a leading role in the Middle East & Africa nucleic acid labelling market profiled in the report are Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Reagents and Kits                

                                                5.1.2.1 Labels    

                                                                5.1.2.1.1 Radioactive Labels

                                                                5.1.2.1.2 Non-Radioactive Labels

                                                5.1.2.2 Probes  

                                                                5.1.2.2.1 Radioactive Probes

                                                                5.1.2.2.2 Non-Radioactive Probes

                                5.1.3 Services                    

                                5.1.4  Y-o-Y Growth Analysis, By Product                              

                                5.1.5  Market Attractiveness Analysis, By Product                            

                                5.1.6  Market Share Analysis, By Product                              

                5.2 Labelling Technique                                

                                5.2.1 Introduction                           

                                5.2.2 PCR                            

                                5.2.3 Nick Translation                    

                                5.2.4 Random Primer                     

                                5.2.5 In-Vitro Transcription                         

                                5.2.6 Reverse Transcription                        

                                5.2.7 End Labelling                          

                                5.2.8 Y-o-Y Growth Analysis, By Labelling Technique                       

                                5.2.9 Market Attractiveness Analysis, By Labelling Technique                     

                                5.2.10 Market Share Analysis, By Labelling Technique                     

                5.3 Application                                 

                                5.3.1 Introduction                           

                                5.3.2 DNA Sequencing                  

                                5.3.3 Polymerase Chain Reaction                             

                                5.3.4 Fluorescence in Situ Hybridization (FISH)                   

                                5.3.5 Microarrays                            

                                5.3.6 Blotting                     

                                5.3.7 In-Situ Hybridization                           

                                5.3.8 Other Applications                               

                                5.3.9 Y-o-Y Growth Analysis, By Application                         

                                5.3.10  Market Attractiveness Analysis, By Application                   

                                5.3.11  Market Share Analysis, By Application                     

                5.4 End-Users                                   

                                5.4.1 Introduction                           

                                5.4.2 Diagnostic Centres                               

                                5.4.3 Research Centres                 

                                5.4.4 Hospitals                  

                                5.4.5 Y-o-Y Growth Analysis, By End-Users                          

                                5.4.6  Market Attractiveness Analysis, By End-Users                       

                                5.4.7  Market Share Analysis, By End-Users                         

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Labelling Technique   

                                                6.1.3.4 By Application    

                                                6.1.3.5 By End-Users      

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Labelling Technique   

                                                6.1.4.4 By Application    

                                                6.1.4.5 By End-Users      

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Labelling Technique   

                                                6.1.5.4 By Application    

                                                6.1.5.5 By End-Users      

                6.2 Middle-East                                                

                6.3 Africa                                            

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Thermo Fisher Scientific                                        

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 New England Biolabs                                              

                8.3 PerkinElmer                                               

                8.4 F.Hoffmann La-Roche AG                                     

                8.5 General Electric Company                                    

                8.6 Merck KGaA                                               

                8.7 Enzo Biochem                                            

                8.8 Promega Corporation                                            

                8.9 Vector Laboratories                                

                8.10 Agilent Technologies                                            

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. Middle East & Africa Nucleic Acid Labelling Market, By Products, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Reagents & Kits Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Services Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Nucleic Acid Labelling Market, By Labelling Technique, From 2022 - 2027 (USD Million)
  5. Middle East & Africa PCR Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Nick Translation Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Random Primer Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa In-Vitro Transcription Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Reverse Transcription Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Nucleic Acid Labelling Market, By Application, From 2022 - 2027 (USD Million)
  11. Middle East & Africa DNA Sequencing Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Polymerase Chain Reactions Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Fluorescence in Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Microarrays Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Blotting Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa In-Situ Hybridization Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Nucleic Acid Labelling Market, By End-Users, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Diagnostic Centres Market, By Region, From 2022 - 2027 (USD Million)
  19. Middle East & Africa Research Centres Market, By Region, From 2022 - 2027 (USD Million)
  20. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  21. Middle East Nucleic Acid Labelling Market, By Products, From 2022 - 2027 (USD Million)
  22. Middle East Nucleic Acid Labelling Market, By Labelling Technique, From 2022 - 2027 (USD Million)
  23. Middle East Nucleic Acid Labelling Market, By Application, From 2022 - 2027 (USD Million)
  24. Middle East Nucleic Acid Labelling Market, By End-Users, From 2022 - 2027 (USD Million)
  25. Africa Nucleic Acid Labelling Market, By Products, From 2022 - 2027 (USD Million)
  26. Africa Nucleic Acid Labelling Market, By Labelling Technique, From 2022 - 2027 (USD Million)
  27. Africa Nucleic Acid Labelling Market, By Application, From 2022 - 2027 (USD Million)
  28. Africa Nucleic Acid Labelling Market, By End-Users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample